Page last updated: 2024-09-04

docetaxel anhydrous and Chromosome Instability Syndromes

docetaxel anhydrous has been researched along with Chromosome Instability Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Beer, TM; Beltran, H; Bergman, AM; Bianchini, D; Castro, E; Chi, KN; Conteduca, V; Cotait Maluf, F; De Giorgi, U; Di Lorenzo, G; Gillessen, S; Hansen, AR; Higano, C; Karalis, K; Klingbiel, D; Kuppen, MCP; Lavaud, P; Le, ML; Ledet, E; Martinez Chanza, N; Mehra, N; Morales-Barrera, R; Oh, WK; Omlin, A; Pezaro, C; Sartor, O; Schär, S; Schmid, S; Suzuki, H; Sweeney, C; Tsao, CK; Tucci, M; Vargas Pivato de Almeida, D; Yip, SM; Zivi, A; Zürrer-Härdi, U1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Chromosome Instability Syndromes

ArticleYear
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
    JAMA network open, 2020, 10-01, Volume: 3, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; DNA Repair-Deficiency Disorders; Docetaxel; Drug Therapy; Humans; Male; Middle Aged; Paclitaxel; Platinum Compounds; Prostatic Neoplasms; Retrospective Studies

2020